KIF4A Facilitates Oxaliplatin Resistance and Stemness in Colon Cancer by Boosting Glucose Metabolism
KIF4A is significantly upregulated in CC to reinforce the glycolysis of cancer cells, thus facilitating cell stemness and resistance to OXA-based therapy.
Authors
- Nannan Dai
- Chenyang Ge
- Zhekang Jin
- Xingxing Yu (ORCID: https://orcid.org/0000-0002-6370-3163)
- Kangfu Dai
- Xia Zhang (ORCID: https://orcid.org/0000-0002-0382-7084)
- Jianping Wang (ORCID: https://orcid.org/0000-0002-5596-7070)
- Cheng Cai (ORCID: https://orcid.org/0000-0001-8994-9674)
- Shicheng Zhou
Institutions
- Zhejiang University (CN)
Publication Details
- Journal
- Digestion
- Published
- 2025-03-27
- DOI
- https://doi.org/10.1159/000544914
- Citations
- 1
- Primary Topic
- Microtubule and mitosis dynamics
- Type
- article
- Field-Weighted Citation Impact
- 1.15